Skip to Content

Renovacor, Inc.

Merger

  • Date:
  • 9/20/2022
  • Company Name:
  • Renovacor, Inc.
  • Stock Symbol:
  • RCOR
  • Company Name - Buyer:
  • Rocket Pharmaceuticals, Inc.
  • Stock Symbol - Buyer:
  • RCKT
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 9/20/2022

Case Finder

Locate any case using the tools below.

NEW YORK, September 20, 2022 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Renovacor, Inc. (NYSE: RCOR) (“Renovacor”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”).

On September 20, 2022, Renovacor announced that it had entered into an agreement to be acquired by Rocket in an all-stock deal with an enterprise value of approximately $53 million. Pursuant to the merger agreement, Renovacor shareholders will receive approximately 0.1676 shares of Rocket in exchange for each of their shares in Renovacor and are expected to own approximately 4.6% percent of Rocket equity on a fully diluted basis immediately following the closing of the transaction. The deal is expected to close in the first quarter of 2023.

Bragar Eagel & Squire is concerned that Renovacor’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Renovacor’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Renovacor. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: